Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Idiopathic pulmonary fibrosis.

Dempsey OJ, Miller D.

BMJ. 2013 Nov 7;347:f6579. doi: 10.1136/bmj.f6579. No abstract available.

PMID:
24201334
2.

Pirfenidone.

Richeldi L, Yasothan U, Kirkpatrick P.

Nat Rev Drug Discov. 2011 Jul;10(7):489-90. No abstract available.

PMID:
21837822
3.

[Idiopathic pulmonary fibrosis: treatment with pirfenidone].

Cano-Jiménez E.

Arch Bronconeumol. 2012 Oct;48 Suppl 2:16-8. Spanish. No abstract available.

PMID:
23630972
4.

Evolvement of best practice in diagnosis and management of idiopathic pulmonary fibrosis.

Poletti V.

Eur Respir Rev. 2014 Mar 1;23(131):3-4. doi: 10.1183/09059180.00008713. No abstract available.

5.

[Characteristics and management of idiopathic pulmonary fibrosis: INSIGHTS-IPF registry].

Behr J, Hoeper MM, Kreuter M, Klotsche J, Wirtz H, Pittrow D.

Dtsch Med Wochenschr. 2012 Dec;137(49):2586-8. doi: 10.1055/s-0032-1327244. Epub 2012 Nov 27. Review. German.

PMID:
23188642
6.

[Idiopathic pulmonary fibrosis: modern guideline-concordant diagnostics and innovative treatment].

Behr J.

Dtsch Med Wochenschr. 2012 Mar;137(12):601-4. doi: 10.1055/s-0031-1299003. Epub 2012 Mar 13. Review. German.

PMID:
22415624
7.

Idiopathic pulmonary fibrosis and pirfenidone.

Collard HR.

Eur Respir J. 2010 Apr;35(4):728-9. doi: 10.1183/09031936.00006610. No abstract available.

8.

Idiopathic pulmonary fibrosis: the turning point is now!

Funke M, Geiser T.

Swiss Med Wkly. 2015 May 29;145:w14139. doi: 10.4414/smw.2015.14139. eCollection 2015. Review.

9.

New guideline on treatment of idiopathic pulmonary fibrosis.

Spagnolo P, Bonella F, Maher TM.

Lancet Respir Med. 2015 Sep;3(9):e31-2. doi: 10.1016/S2213-2600(15)00322-7. No abstract available.

PMID:
26380887
10.

Pirfenidone treatment of idiopathic pulmonary fibrosis.

Azuma A.

Ther Adv Respir Dis. 2012 Apr;6(2):107-14. doi: 10.1177/1753465812436663. Epub 2012 Feb 14. Review.

PMID:
22333982
11.

Hot off the breath: A big step forward for idiopathic pulmonary fibrosis.

Ryerson CJ, Collard HR.

Thorax. 2014 Sep;69(9):791-2. doi: 10.1136/thoraxjnl-2014-205892. Epub 2014 Jul 4. No abstract available.

PMID:
24996636
12.

Changing the idiopathic pulmonary fibrosis treatment approach and improving patient outcomes.

Cottin V.

Eur Respir Rev. 2012 Jun 1;21(124):161-7. doi: 10.1183/09059180.00001112. Review.

13.

[Antifibrotic treatment].

von der Beck D, Löh B, Drakopanagiotakis F, Markart P, Günther A.

Dtsch Med Wochenschr. 2014 Dec;139(49):2523-5. doi: 10.1055/s-0034-1387450. Epub 2014 Nov 25. Review. German. No abstract available.

PMID:
25423462
14.

[S2K guideline on diagnosis and treatment of idiopathic pulmonary fibrosis].

Borchardt J.

Pneumologie. 2013 Jun;67(6):356. doi: 10.1055/s-0033-1344177. Epub 2013 Jun 7. German. No abstract available.

15.

InterMune and Boehringer blaze trails for idiopathic pulmonary fibrosis drugs.

Kingwell K.

Nat Rev Drug Discov. 2014 Jul;13(7):483-4. doi: 10.1038/nrd4382. No abstract available.

PMID:
24981347
16.

An Unusual Case of Hypoxemia Improving Overnight in Idiopathic Pulmonary Fibrosis.

Carlucci A, Ceriana P, Micheletti A, Schreiber A, Butera G.

J Cardiothorac Vasc Anesth. 2015 Oct;29(5):e64-6. doi: 10.1053/j.jvca.2015.04.018. Epub 2015 Apr 28. No abstract available.

PMID:
26119407
17.

Pharmacological therapy does not contribute to survival in idiopathic pulmonary fibrosis.

Ishii H, Kushima H, Komiya K, Mizunoe S, Kadota J.

Respiration. 2013;86(1):86-7. doi: 10.1159/000348545. Epub 2013 Apr 9. No abstract available.

PMID:
23594834
18.

Pirfenidone treatment in idiopathic pulmonary fibrosis: too much of a great expectation?

Papiris SA, Kagouridis K, Kolilekas L, Triantafillidou C, Tsangaris I, Manali ED.

Eur Respir J. 2012 Sep;40(3):794-5. doi: 10.1183/09031936.00114311. No abstract available.

19.

Treating idiopathic pulmonary fibrosis: current opportunities and future challenges.

Richeldi L.

Clin Respir J. 2012 Jul;6(3):129-30. doi: 10.1111/j.1752-699X.2012.00303.x. No abstract available.

PMID:
22697263
20.

Nintedanib and pirfenidone. New antifibrotic treatments indicated for idiopathic pulmonary fibrosis offer hopes and raises questions.

Raghu G, Selman M.

Am J Respir Crit Care Med. 2015 Feb 1;191(3):252-4. doi: 10.1164/rccm.201411-2044ED. No abstract available.

PMID:
25635489

Supplemental Content

Support Center